OUR MISSION
We believe cost should never prevent someone from exploring treatment options that may improve their quality of life. That’s why Bridgeway is committed to providing compassionate, physician-guided ketamine therapy with transparent pricing and affordable treatment options.
Veteran-Led Care
Dr. Sean Cady’s military background influences the way Bridgeway cares for patients – with integrity, compassion, and a commitment to serving others. That same mindset guides every patient interaction.
Conditions We Currently Treat
Bridgeway provides physician-guided ketamine therapy for individuals exploring treatment options for mental health and chronic pain.
Treatment-Resistant Depression
For individuals who continue to experience significant depressive symptoms after trying standard treatment approaches.
Chronic Pain
A different approach for conditions such as CRPS, neuropathy, fibromyalgia, and other persistent pain disorders.
How Ketamine Therapy Works
Ketamine is an anesthetic medication that acts in part through the brain’s glutamate system. Clinical research has found rapid antidepressant effects in some patients with treatment-resistant depression, while research into its use for chronic pain and other psychiatric conditions continues to evolve. Use of IV ketamine for psychiatric conditions is off-label.
Research has evaluated IV ketamine as an off-label treatment option for some patients whose depressive symptoms have not adequately responded to standard treatments.
Getting Started Is Simple
Preparation & Integration Coaching Through Being True To You
Bridgeway partners with Being True To You to provide preparation and integration coaching that helps patients get the most from their ketamine therapy experience. Rather than focusing on the past, coaching is designed to help patients move forward with greater clarity, establish healthy habits, and apply new insights to everyday life.
Start Your Journey with Bridgeway Today
Important Treatment Information:
Ketamine is FDA-approved as an anesthetic. ¹ The use of IV ketamine for depression and chronic pain is off-label and is not an FDA-approved indication for ketamine injection. Treatment is not appropriate for everyone. Potential benefits, risks, alternatives and expected outcomes should be discussed with a qualified medical provider.
FDA’s 2026 Ketalar label lists anesthesia indications, and FDA has specifically stated that ketamine itself is not FDA-approved for psychiatric disorders. (FDA Access Data)